TIFFANY BLAZ: Open Payments
NPI 1942721741 · ZANESVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$814 in 59 payments from 16 companies in 2025. Trend: 2023 $411 · 2024 $383 · 2025 $814
Food & beverage: $814
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $209 |
| Novo Nordisk Inc | 6 | $103 |
| Phathom Pharmaceuticals, Inc. | 9 | $81 |
| AstraZeneca Pharmaceuticals LP | 4 | $65 |
| Corcept Therapeutics | 2 | $55 |
| PFIZER INC. | 3 | $52 |
| Astellas Pharma US Inc | 2 | $43 |
| Amgen Inc. | 2 | $34 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| Medtronic, Inc. | 1 | $30 |
Products named: VRAYLAR, VOQUEZNA, Ozempic, QULIPTA, Korlym, AIRSUPRA, Veozah, UBRELVY.
Industry payments across OH — which companies pay providers there.
